155 related articles for article (PubMed ID: 15130257)
1. Adherence to oral therapies in pelvic inflammatory disease.
Dunbar-Jacob J; Sereika SM; Foley SM; Bass DC; Ness RB
J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
[TBL] [Abstract][Full Text] [Related]
3. Trends in illness severity and length of stay in inner-city adolescents hospitalized for pelvic inflammatory disease.
Kaul P; Stevens-Simon C; Saproo A; Coupey SM
J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):289-93. PubMed ID: 18794025
[TBL] [Abstract][Full Text] [Related]
4. Use of an institutional intervention to improve quality of care for adolescents treated in pediatric ambulatory settings for pelvic inflammatory disease.
Trent M; Judy SL; Ellen JM; Walker A
J Adolesc Health; 2006 Jul; 39(1):50-6. PubMed ID: 16781961
[TBL] [Abstract][Full Text] [Related]
5. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.
Mugo NR; Kiehlbauch JA; Nguti R; Meier A; Gichuhi JW; Stamm WE; Cohen CR
Obstet Gynecol; 2006 Apr; 107(4):807-12. PubMed ID: 16582116
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
[TBL] [Abstract][Full Text] [Related]
7. Ascertaining how much compliance is enough with outpatient antibiotic regimens.
Urquhart J
Postgrad Med J; 1992; 68 Suppl 3():S49-58; discussion S59. PubMed ID: 1287619
[TBL] [Abstract][Full Text] [Related]
8. [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
Fischbach F; Deckardt R; Graeff H
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):337-40. PubMed ID: 8088489
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
Piyadigamage A; Wilson J
Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
Heystek M; Ross JD;
Int J STD AIDS; 2009 Oct; 20(10):690-5. PubMed ID: 19815913
[TBL] [Abstract][Full Text] [Related]
11. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.
Wølner-Hanssen P; Paavonen J; Kiviat N; Young M; Eschenbach DA; Holmes KK
Obstet Gynecol; 1988 Apr; 71(4):595-600. PubMed ID: 3353051
[TBL] [Abstract][Full Text] [Related]
12. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P
Scand J Infect Dis Suppl; 1989; 60():66-73. PubMed ID: 2756353
[TBL] [Abstract][Full Text] [Related]
13. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
[TBL] [Abstract][Full Text] [Related]
14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis].
Vasiljević M; Marković A; Ganović R; Jovanović R
Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846
[TBL] [Abstract][Full Text] [Related]
16. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
Trent M; Chung SE; Forrest L; Ellen JM
Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
[TBL] [Abstract][Full Text] [Related]
17. Factors contributing to compliance with osteoporosis medication.
Kertes J; Dushenat M; Vesterman JL; Lemberger J; Bregman J; Friedman N
Isr Med Assoc J; 2008 Mar; 10(3):207-13. PubMed ID: 18494234
[TBL] [Abstract][Full Text] [Related]
18. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
Haggerty CL; Ness RB
Clin Infect Dis; 2007 Apr; 44(7):953-60. PubMed ID: 17342647
[TBL] [Abstract][Full Text] [Related]
19. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J
Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
[TBL] [Abstract][Full Text] [Related]
20. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
